Organon Share Holder Equity 2019-2025 | OGN

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Organon share holder equity from 2019 to 2025. Share holder equity can be defined as the sum of preferred and common equity items

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Organon share holder equity from 2019 to 2025. Share holder equity can be defined as the sum of preferred and common equity items

Related Stocks
Company Name	Market Cap
Danaher (DHR)	$145.3B
CVS Health (CVS)	$75.4B
Elevance Health (ELV)	$64.4B
Cencora (COR)	$55.5B
DiDi Global (DIDIY)	$26B
Labcorp Holdings (LH)	$21.9B
Natera (NTRA)	$18.8B
BioMerieux (BMXMF)	$17.1B
ICON (ICLR)	$15.3B
EUROFINS SCIENT (ERFSF)	$14.9B
CochLear (CHEOY)	$13.4B
Solventum (SOLV)	$12.8B
Medpace Holdings (MEDP)	$12.7B
Revvity (RVTY)	$11.2B
Viatris (VTRS)	$10.9B
Avantor (AVTR)	$9.5B
Sonic Healthcare (SKHHY)	$9.2B
Charles River Laboratories (CRL)	$8.8B
HealthEquity (HQY)	$8.3B
Caris Life Sciences,�Inc (CAI)	$6.9B
Amplifon S.p.A (AMFPF)	$5.4B
Bausch + Lomb (BLCO)	$5.1B
BrightSpring Health Services (BTSG)	$3.6B
Sotera Health (SHC)	$3.5B
Surgery Partners (SGRY)	$2.9B
Concentras Parent (CON)	$2.6B
GeneDx Holdings (WGS)	$2.4B
Alignment Healthcare (ALHC)	$2.3B
Progyny (PGNY)	$2B
PACS (PACS)	$1.8B